Skip to content

Clinical trial on comparing the effect of vaginal Shallomine containing the pure fraction of shallot extract and clotrimazole in treatment of candidal vaginitis

Assessing the effect of vaginal Shallomine containing pure fraction of shallot extract and clotrimazole in treatment of candidal vaginitis

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20190728044356N1
Enrollment
30
Registered
2020-12-07
Start date
2020-09-22
Completion date
Unknown
Last updated
2021-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: Candidiasis. Condition 2: Candidiasis of vulva and vagin. Candidiasis Candidiasis of vulva and vagina

Interventions

Intervention 1: Intervention group: Shalomine, 2 cc, deep vaginal inoculation with sterile syringe, twice daily for 5 days. Intervention 2: Intervention group: Clotrimazole, daily for one week.

Sponsors

Ahvaz University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 50 Years

Inclusion criteria

Inclusion criteria: aged between 18 and 50 years Be married Have 1 spouse Have consent to participate in the study Not allergic to herbal medicines Not allergic to clotrimazole Be literate

Exclusion criteria

Exclusion criteria: They have been taken antibiotics and corticosteroids for the past two weeks, according to the participant Have any sores or lumps in the cervix based on observation with speculum Present use of other herbal medicines Have abnormal uterine bleeding

Design outcomes

Primary

MeasureTime frame
Percentage of people with candidal vaginitis. Timepoint: Examination of Candida in the patient's vaginal discharge before the intervention and one week after taking the drug. Method of measurement: culture and Laboratory diagnosis of Candida.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSousan Akrami

Ahvaz University of Medical Sciences

sahm647094@gmail.com+98 61 3373 8283

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026